Beam Therapeutics Inc. BEAM

Set alert

26.33 USD +0.46 (+1.78%)

At closeNov 4, 2026, 6:21 AM EST

27.01 +0.68 +2.58%

Pre-market · Nov 4, 6:21 AM ET

25.99 Day range 27.20

20.23 52-week range 38.26

Held by insiders 1.20%

Held by institutions 107.81%

Float held by institutions 109.12%

Institutions 392

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	12.21%	12,609,002	332.00M	Jun 29, 2026
Farallon Capital Management LLC	9.91%	10,236,396	269.52M	Jun 29, 2026
ARK Investment Management, LLC	9.91%	10,234,862	269.48M	Jun 29, 2026
Blackrock Inc.	8.71%	8,997,542	236.91M	Jun 29, 2026
State Street Corporation	5.64%	5,827,122	153.43M	Jun 29, 2026
Vanguard Portfolio Management LLC	4.76%	4,921,259	129.58M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
ARK ETF Trust-ARK Innovation ETF	7.33%	7,575,673	199.47M	Sep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	3.35%	3,457,347	91.03M	Aug 30, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	3.33%	3,441,420	90.61M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	3.17%	3,273,307	86.19M	Jun 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF	2.61%	2,696,956	71.01M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.49%	2,569,276	67.65M	Sep 29, 2026

BEAM insiders
Insider	Relation	Latest transaction	Date	Shares held
BELLON CHRISTINE	Officer	Sale	Mar 31, 2026	109,711
CAVANAGH BETHANY J	Officer and Treasurer	Sale	Mar 31, 2026	51,171
CIARAMELLA GIUSEPPE	President	Conversion of Exercise of derivative security	Jun 16, 2026	253,911
EMANY SRAVAN KUMAR	Chief Financial Officer	Stock Award(Grant)	Mar 30, 2026	105,456
EVANS JOHN M.	Chief Executive Officer	Sale	Jun 29, 2026	1,150,200
FMR, L.L.C.	Beneficial Owner of more than 10% of a Class of Security	Sale	Jun 25, 2026	0

Held by funds